Ha-Neui Kim
Concepts (302)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoclasts | 23 | 2021 | 428 | 3.500 |
Why?
| | Bone Resorption | 12 | 2020 | 302 | 2.260 |
Why?
| | Aging | 6 | 2021 | 701 | 1.980 |
Why?
| | Osteogenesis | 7 | 2020 | 366 | 1.920 |
Why?
| | RANK Ligand | 13 | 2020 | 187 | 1.450 |
Why?
| | Osteoporosis | 3 | 2021 | 162 | 1.290 |
Why?
| | Bone and Bones | 9 | 2020 | 494 | 1.180 |
Why?
| | Mitochondria | 3 | 2021 | 430 | 1.170 |
Why?
| | Histone Deacetylase Inhibitors | 3 | 2012 | 58 | 1.050 |
Why?
| | Osteoblasts | 10 | 2021 | 475 | 1.030 |
Why?
| | Estrogens | 4 | 2021 | 223 | 0.940 |
Why?
| | Proto-Oncogene Proteins c-fos | 7 | 2013 | 60 | 0.920 |
Why?
| | Mice | 28 | 2021 | 5949 | 0.810 |
Why?
| | Forkhead Transcription Factors | 4 | 2017 | 116 | 0.810 |
Why?
| | Cell Differentiation | 13 | 2020 | 665 | 0.760 |
Why?
| | Carcinoma, Hepatocellular | 6 | 2010 | 202 | 0.760 |
Why?
| | Benzamides | 2 | 2012 | 50 | 0.750 |
Why?
| | Hepatitis B virus | 4 | 2009 | 24 | 0.750 |
Why?
| | Adenosine Triphosphate | 2 | 2020 | 205 | 0.750 |
Why?
| | Sirtuin 3 | 1 | 2021 | 18 | 0.720 |
Why?
| | Hepatitis B, Chronic | 3 | 2010 | 17 | 0.710 |
Why?
| | Pyridines | 2 | 2012 | 132 | 0.700 |
Why?
| | Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.690 |
Why?
| | Bone Density | 3 | 2020 | 399 | 0.690 |
Why?
| | Stem Cells | 3 | 2019 | 177 | 0.680 |
Why?
| | Oxidative Phosphorylation | 1 | 2020 | 46 | 0.670 |
Why?
| | Animals | 31 | 2021 | 13505 | 0.650 |
Why?
| | Sirtuin 1 | 2 | 2015 | 29 | 0.600 |
Why?
| | Osteocytes | 1 | 2020 | 226 | 0.560 |
Why?
| | Liver Abscess, Pyogenic | 1 | 2016 | 1 | 0.510 |
Why?
| | Cecal Diseases | 1 | 2016 | 7 | 0.510 |
Why?
| | Ulcer | 1 | 2016 | 25 | 0.500 |
Why?
| | Signal Transduction | 9 | 2020 | 1671 | 0.490 |
Why?
| | Liver Cirrhosis | 4 | 2011 | 240 | 0.460 |
Why?
| | Mice, Knockout | 4 | 2021 | 879 | 0.460 |
Why?
| | Liver Neoplasms | 5 | 2010 | 333 | 0.450 |
Why?
| | Transcription, Genetic | 2 | 2015 | 378 | 0.440 |
Why?
| | Hepatitis B e Antigens | 2 | 2010 | 4 | 0.420 |
Why?
| | Bone Marrow Cells | 10 | 2015 | 190 | 0.410 |
Why?
| | Mice, Inbred C57BL | 8 | 2020 | 1884 | 0.410 |
Why?
| | Down-Regulation | 3 | 2012 | 346 | 0.390 |
Why?
| | Trans-Activators | 2 | 2010 | 135 | 0.380 |
Why?
| | NFATC Transcription Factors | 5 | 2013 | 23 | 0.370 |
Why?
| | Antiviral Agents | 2 | 2010 | 178 | 0.370 |
Why?
| | DEAD-box RNA Helicases | 1 | 2011 | 34 | 0.360 |
Why?
| | Alkaline Phosphatase | 1 | 2011 | 94 | 0.360 |
Why?
| | Arabinofuranosyluracil | 1 | 2010 | 1 | 0.340 |
Why?
| | Lamivudine | 1 | 2010 | 6 | 0.340 |
Why?
| | Female | 22 | 2021 | 28171 | 0.340 |
Why?
| | Ribavirin | 1 | 2010 | 15 | 0.330 |
Why?
| | Interferon-alpha | 1 | 2010 | 53 | 0.330 |
Why?
| | Gene Expression Regulation | 6 | 2020 | 990 | 0.320 |
Why?
| | Hydroxamic Acids | 1 | 2009 | 38 | 0.320 |
Why?
| | Male | 28 | 2021 | 26761 | 0.320 |
Why?
| | Polyethylene Glycols | 1 | 2010 | 90 | 0.320 |
Why?
| | Mutation, Missense | 1 | 2009 | 108 | 0.310 |
Why?
| | Hepatitis C, Chronic | 1 | 2010 | 86 | 0.300 |
Why?
| | Cells, Cultured | 9 | 2020 | 1567 | 0.300 |
Why?
| | NF-kappa B | 3 | 2017 | 322 | 0.300 |
Why?
| | Mice, Transgenic | 2 | 2019 | 552 | 0.260 |
Why?
| | Mice, Inbred ICR | 6 | 2013 | 25 | 0.260 |
Why?
| | Coculture Techniques | 6 | 2013 | 144 | 0.250 |
Why?
| | Estrogen Receptor alpha | 3 | 2016 | 85 | 0.250 |
Why?
| | Skin Neoplasms | 2 | 2007 | 505 | 0.230 |
Why?
| | Bone Neoplasms | 3 | 2012 | 184 | 0.220 |
Why?
| | Interleukin-1 | 4 | 2013 | 107 | 0.220 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 649 | 0.200 |
Why?
| | Cell Count | 2 | 2020 | 149 | 0.200 |
Why?
| | Chemokine CXCL12 | 2 | 2020 | 32 | 0.200 |
Why?
| | Bone Remodeling | 3 | 2020 | 155 | 0.190 |
Why?
| | Humans | 24 | 2017 | 52483 | 0.180 |
Why?
| | Cell Lineage | 3 | 2016 | 85 | 0.180 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2016 | 603 | 0.180 |
Why?
| | Osteolysis | 2 | 2012 | 75 | 0.170 |
Why?
| | Porosity | 2 | 2017 | 31 | 0.170 |
Why?
| | Sequence Analysis, DNA | 3 | 2012 | 229 | 0.170 |
Why?
| | Adipogenesis | 1 | 2020 | 49 | 0.170 |
Why?
| | Chemokine CXCL10 | 2 | 2012 | 20 | 0.170 |
Why?
| | Tomography, X-Ray Computed | 5 | 2016 | 1165 | 0.170 |
Why?
| | Phospholipids | 1 | 2020 | 59 | 0.170 |
Why?
| | Middle Aged | 10 | 2016 | 13028 | 0.170 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2016 | 84 | 0.160 |
Why?
| | Dinoprostone | 3 | 2009 | 49 | 0.160 |
Why?
| | Mutation | 2 | 2017 | 1347 | 0.150 |
Why?
| | Osteoprotegerin | 4 | 2013 | 53 | 0.150 |
Why?
| | Phenanthrenes | 2 | 2008 | 13 | 0.140 |
Why?
| | Sulfonamides | 2 | 2017 | 133 | 0.140 |
Why?
| | Hydrogen Peroxide | 2 | 2016 | 120 | 0.140 |
Why?
| | GATA4 Transcription Factor | 1 | 2017 | 11 | 0.140 |
Why?
| | G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 17 | 0.140 |
Why?
| | Panniculitis | 1 | 2017 | 8 | 0.140 |
Why?
| | Primary Cell Culture | 1 | 2017 | 62 | 0.140 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 68 | 0.140 |
Why?
| | Enzyme Activation | 2 | 2015 | 270 | 0.140 |
Why?
| | Genes, Reporter | 1 | 2017 | 88 | 0.130 |
Why?
| | Luminescent Proteins | 1 | 2017 | 54 | 0.130 |
Why?
| | Pancreatitis, Chronic | 1 | 2017 | 11 | 0.130 |
Why?
| | Base Sequence | 3 | 2014 | 640 | 0.130 |
Why?
| | Aniline Compounds | 1 | 2017 | 46 | 0.130 |
Why?
| | DNA, Viral | 2 | 2009 | 137 | 0.130 |
Why?
| | Interleukin-2 | 1 | 2016 | 69 | 0.130 |
Why?
| | Gonadal Steroid Hormones | 1 | 2016 | 39 | 0.130 |
Why?
| | Apoptosis | 2 | 2020 | 1119 | 0.130 |
Why?
| | Graft vs Host Disease | 1 | 2016 | 87 | 0.130 |
Why?
| | Killer Cells, Natural | 1 | 2016 | 116 | 0.120 |
Why?
| | Heme Oxygenase-1 | 1 | 2015 | 18 | 0.120 |
Why?
| | Antioxidants | 2 | 2009 | 256 | 0.120 |
Why?
| | Acetylation | 1 | 2015 | 95 | 0.120 |
Why?
| | Adult | 11 | 2017 | 14161 | 0.120 |
Why?
| | Colonoscopy | 1 | 2016 | 108 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2017 | 221 | 0.120 |
Why?
| | DNA Damage | 1 | 2017 | 305 | 0.120 |
Why?
| | Receptors, Androgen | 1 | 2015 | 46 | 0.120 |
Why?
| | Liver | 2 | 2016 | 1156 | 0.120 |
Why?
| | Androgens | 1 | 2015 | 70 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2015 | 155 | 0.120 |
Why?
| | Histones | 1 | 2017 | 314 | 0.120 |
Why?
| | Hematologic Neoplasms | 1 | 2016 | 106 | 0.110 |
Why?
| | Aged | 8 | 2016 | 10121 | 0.110 |
Why?
| | Catalase | 1 | 2014 | 73 | 0.110 |
Why?
| | Bone Development | 1 | 2014 | 66 | 0.110 |
Why?
| | Laparoscopy | 1 | 2016 | 180 | 0.110 |
Why?
| | Trapidil | 1 | 2013 | 1 | 0.110 |
Why?
| | beta Catenin | 1 | 2014 | 102 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 778 | 0.110 |
Why?
| | Viral Regulatory and Accessory Proteins | 2 | 2010 | 6 | 0.100 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2014 | 179 | 0.100 |
Why?
| | Bone Density Conservation Agents | 1 | 2013 | 75 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2012 | 335 | 0.100 |
Why?
| | Ovariectomy | 3 | 2020 | 113 | 0.100 |
Why?
| | Antibodies, Monoclonal | 1 | 2016 | 481 | 0.100 |
Why?
| | Osteogenesis Imperfecta | 1 | 2012 | 37 | 0.100 |
Why?
| | Models, Biological | 1 | 2015 | 735 | 0.100 |
Why?
| | Cell Nucleus | 1 | 2013 | 187 | 0.100 |
Why?
| | Cell Line | 2 | 2012 | 1030 | 0.100 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 421 | 0.090 |
Why?
| | Janus Kinase 2 | 2 | 2008 | 25 | 0.090 |
Why?
| | Viral Load | 2 | 2010 | 82 | 0.090 |
Why?
| | Korea | 2 | 2009 | 10 | 0.090 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2013 | 181 | 0.090 |
Why?
| | Response Elements | 1 | 2011 | 29 | 0.090 |
Why?
| | Gene Deletion | 3 | 2020 | 272 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2011 | 108 | 0.090 |
Why?
| | Metronidazole | 1 | 2011 | 28 | 0.090 |
Why?
| | Hepatic Encephalopathy | 1 | 2011 | 29 | 0.090 |
Why?
| | Genotype | 2 | 2010 | 566 | 0.090 |
Why?
| | Isoenzymes | 1 | 2011 | 166 | 0.090 |
Why?
| | Lipopolysaccharides | 2 | 2009 | 206 | 0.090 |
Why?
| | Histone Deacetylases | 1 | 2011 | 51 | 0.090 |
Why?
| | Bone Regeneration | 1 | 2011 | 70 | 0.090 |
Why?
| | Neoplasm Invasiveness | 2 | 2009 | 278 | 0.090 |
Why?
| | Brain Diseases | 1 | 2011 | 79 | 0.090 |
Why?
| | Drug Resistance, Viral | 1 | 2010 | 8 | 0.090 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 34 | 0.090 |
Why?
| | Vitamin E | 1 | 2011 | 77 | 0.080 |
Why?
| | Enhancer Elements, Genetic | 1 | 2010 | 58 | 0.080 |
Why?
| | Anti-Infective Agents | 1 | 2011 | 107 | 0.080 |
Why?
| | Liver Function Tests | 1 | 2010 | 48 | 0.080 |
Why?
| | Osteitis | 1 | 2009 | 1 | 0.080 |
Why?
| | Catechin | 1 | 2009 | 16 | 0.080 |
Why?
| | Protein Binding | 1 | 2011 | 667 | 0.080 |
Why?
| | Hepatitis B Surface Antigens | 1 | 2009 | 6 | 0.080 |
Why?
| | Protein Precursors | 1 | 2009 | 42 | 0.080 |
Why?
| | Viral Envelope Proteins | 1 | 2009 | 35 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2010 | 5422 | 0.080 |
Why?
| | RNA, Viral | 1 | 2010 | 127 | 0.080 |
Why?
| | Skull | 1 | 2009 | 80 | 0.080 |
Why?
| | Gallbladder Neoplasms | 1 | 2009 | 7 | 0.080 |
Why?
| | Macrophages | 2 | 2009 | 379 | 0.080 |
Why?
| | Tyrphostins | 1 | 2008 | 9 | 0.080 |
Why?
| | Chromans | 1 | 2009 | 35 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 582 | 0.080 |
Why?
| | Iodized Oil | 1 | 2008 | 1 | 0.080 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 82 | 0.070 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2008 | 13 | 0.070 |
Why?
| | Intracranial Embolism | 1 | 2008 | 29 | 0.070 |
Why?
| | Recombinant Proteins | 1 | 2010 | 483 | 0.070 |
Why?
| | Phylogeny | 1 | 2009 | 231 | 0.070 |
Why?
| | Esophagoscopy | 1 | 2008 | 27 | 0.070 |
Why?
| | Toll-Like Receptor 5 | 1 | 2008 | 5 | 0.070 |
Why?
| | MAP Kinase Signaling System | 1 | 2008 | 121 | 0.070 |
Why?
| | STAT1 Transcription Factor | 1 | 2008 | 27 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 169 | 0.070 |
Why?
| | Interferon-beta | 1 | 2008 | 33 | 0.070 |
Why?
| | Promoter Regions, Genetic | 1 | 2010 | 467 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2011 | 1563 | 0.070 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 122 | 0.070 |
Why?
| | Arthritis, Rheumatoid | 1 | 2008 | 116 | 0.070 |
Why?
| | Pulmonary Embolism | 1 | 2008 | 86 | 0.070 |
Why?
| | Common Bile Duct Neoplasms | 1 | 2007 | 11 | 0.070 |
Why?
| | Contrast Media | 1 | 2008 | 193 | 0.070 |
Why?
| | Ampulla of Vater | 1 | 2007 | 17 | 0.070 |
Why?
| | Esophageal Neoplasms | 1 | 2008 | 111 | 0.070 |
Why?
| | Thioctic Acid | 1 | 2006 | 3 | 0.060 |
Why?
| | Cholangitis | 1 | 2005 | 16 | 0.060 |
Why?
| | Rats | 1 | 2011 | 3220 | 0.060 |
Why?
| | X-Ray Microtomography | 2 | 2015 | 79 | 0.060 |
Why?
| | Hepatitis B Core Antigens | 1 | 2004 | 7 | 0.060 |
Why?
| | DNA Primers | 2 | 2014 | 208 | 0.050 |
Why?
| | Organ Size | 2 | 2015 | 228 | 0.050 |
Why?
| | Femur | 2 | 2015 | 135 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2007 | 405 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 185 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2010 | 1212 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2020 | 78 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 80 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 326 | 0.040 |
Why?
| | Blotting, Western | 2 | 2014 | 590 | 0.040 |
Why?
| | Cell Survival | 2 | 2011 | 612 | 0.040 |
Why?
| | Cyclooxygenase 2 | 2 | 2008 | 48 | 0.030 |
Why?
| | Amylases | 1 | 2017 | 4 | 0.030 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2017 | 9 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 1132 | 0.030 |
Why?
| | Lipase | 1 | 2017 | 11 | 0.030 |
Why?
| | Fatal Outcome | 2 | 2008 | 197 | 0.030 |
Why?
| | Laboratories | 1 | 2017 | 21 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2016 | 10 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2012 | 1470 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2017 | 312 | 0.030 |
Why?
| | Erythema | 1 | 2017 | 38 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2016 | 39 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 234 | 0.030 |
Why?
| | Transplantation Immunology | 1 | 2016 | 6 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 2016 | 33 | 0.030 |
Why?
| | Calcification, Physiologic | 1 | 2016 | 42 | 0.030 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 2 | 2006 | 33 | 0.030 |
Why?
| | Myeloproliferative Disorders | 1 | 2016 | 31 | 0.030 |
Why?
| | Induction Chemotherapy | 1 | 2016 | 64 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 150 | 0.030 |
Why?
| | Leukemia | 1 | 2016 | 67 | 0.030 |
Why?
| | Lymphoma | 1 | 2016 | 71 | 0.030 |
Why?
| | Orchiectomy | 1 | 2015 | 38 | 0.030 |
Why?
| | Integrases | 1 | 2015 | 44 | 0.030 |
Why?
| | Membrane Glycoproteins | 2 | 2006 | 244 | 0.030 |
Why?
| | Gene Expression | 2 | 2008 | 618 | 0.030 |
Why?
| | Recurrence | 1 | 2016 | 672 | 0.030 |
Why?
| | Carrier Proteins | 2 | 2006 | 313 | 0.030 |
Why?
| | Wnt Proteins | 1 | 2014 | 100 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-pim-1 | 1 | 2013 | 1 | 0.030 |
Why?
| | Skin | 1 | 2017 | 422 | 0.030 |
Why?
| | Atrophy | 1 | 2013 | 45 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2014 | 554 | 0.030 |
Why?
| | Inflammation | 2 | 2008 | 641 | 0.030 |
Why?
| | Genetic Linkage | 1 | 2012 | 25 | 0.020 |
Why?
| | 5' Untranslated Regions | 1 | 2012 | 30 | 0.020 |
Why?
| | Exome | 1 | 2012 | 55 | 0.020 |
Why?
| | Uterus | 1 | 2013 | 88 | 0.020 |
Why?
| | Spine | 1 | 2013 | 89 | 0.020 |
Why?
| | Point Mutation | 1 | 2012 | 67 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 789 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 235 | 0.020 |
Why?
| | Estradiol | 1 | 2013 | 214 | 0.020 |
Why?
| | Adolescent | 3 | 2012 | 6739 | 0.020 |
Why?
| | Calcium | 1 | 2013 | 376 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 470 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 578 | 0.020 |
Why?
| | Tocotrienols | 1 | 2011 | 37 | 0.020 |
Why?
| | Matrix Metalloproteinases | 1 | 2010 | 47 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2010 | 35 | 0.020 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2010 | 23 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2014 | 1023 | 0.020 |
Why?
| | Tumor Microenvironment | 1 | 2012 | 256 | 0.020 |
Why?
| | Mice, Nude | 1 | 2010 | 265 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2010 | 220 | 0.020 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2010 | 139 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2010 | 138 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 243 | 0.020 |
Why?
| | bcl-Associated Death Protein | 1 | 2008 | 9 | 0.020 |
Why?
| | Cytochromes c | 1 | 2008 | 29 | 0.020 |
Why?
| | Drugs, Chinese Herbal | 1 | 2008 | 9 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2008 | 86 | 0.020 |
Why?
| | Caspases | 1 | 2008 | 104 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2008 | 31 | 0.020 |
Why?
| | Mice, Inbred DBA | 1 | 2008 | 47 | 0.020 |
Why?
| | Flagellin | 1 | 2008 | 4 | 0.020 |
Why?
| | Polyps | 1 | 2008 | 21 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2013 | 807 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2008 | 151 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2008 | 70 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2008 | 183 | 0.020 |
Why?
| | Endosonography | 1 | 2008 | 98 | 0.020 |
Why?
| | Bone Diseases | 1 | 2008 | 96 | 0.020 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2008 | 43 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2008 | 133 | 0.020 |
Why?
| | Ultrasonography | 1 | 2009 | 430 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2009 | 258 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 227 | 0.020 |
Why?
| | Macrophage Colony-Stimulating Factor | 1 | 2006 | 11 | 0.020 |
Why?
| | Immunoblotting | 1 | 2006 | 116 | 0.020 |
Why?
| | Nitrobenzenes | 1 | 2006 | 2 | 0.020 |
Why?
| | Child | 2 | 2012 | 7248 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 857 | 0.020 |
Why?
| | Palliative Care | 1 | 2008 | 214 | 0.020 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2006 | 39 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2008 | 772 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2009 | 1046 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2008 | 979 | 0.010 |
Why?
| | Disease Progression | 1 | 2008 | 871 | 0.010 |
Why?
| | Acute Disease | 1 | 2005 | 373 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2011 | 1546 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2008 | 1478 | 0.010 |
Why?
| | Prognosis | 1 | 2007 | 2099 | 0.010 |
Why?
|
|
Kim's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|